Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study.
Abstract | BACKGROUND: METHODS: We conducted a cross-sectional study between 2013 and 2017, on 384 hemodialysis patients from seven hospital-based-dialysis centers. HOMA-IR is classified according to median value. The CVD risks were defined by the K/DOQI Guidelines. Logistic regression analysis was used. RESULTS: Patients' age was 60.9 ± 11.8, 58.1% men, and 40.3% overweight/obese. The median of HOMA-IR was 5.4, 82.8% high systolic blood pressure, and 85.7% hyperhomocysteinemia. In multivariate analysis, IR was significantly associated with higher odds of low high-density lipoprotein cholesterol, high triglyceride, and impaired fasting glucose in groups of normal weight, overweight/obese, nondiabetes, diabetes, and overall sample. IR linked with elevated high-sensitive C-reactive protein in normal weight patients (odd ratio, OR=2.21, 95% confidence interval, 1.16-4.22, p < .05), with hypoalbuminemia in normal weight patients (OR=8.31, 95% CI, 2.35-29.37, p < .01), in nondiabetes patients (OR=6.59, 95% CI, 1.81-23.95, p < .01), and overall sample (OR=3.07, 1.51-6.23, p < .01). CONCLUSIONS: The level of IR and prevalence of CVD risks were high in hemodialysis patients. IR was independently associated with CVD risks.
|
Authors | Tuyen Van Duong, Chun-Kuang Shih, Te-Chih Wong, Hsi-Hsien Chen, Tso-Hsiao Chen, Yung-Ho Hsu, Sheng-Jeng Peng, Ko-Lin Kuo, Hsiang-Chung Liu, En-Tzu Lin, Chien-Tien Su, Shwu-Huey Yang |
Journal | BioMed research international
(Biomed Res Int)
Vol. 2019
Pg. 1541593
( 2019)
ISSN: 2314-6141 [Electronic] United States |
PMID | 31309101
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
|
Topics |
- Blood Pressure
(physiology)
- Body Mass Index
- Cardiovascular Diseases
(blood, etiology)
- Cross-Sectional Studies
- Female
- Humans
- Insulin
(blood)
- Insulin Resistance
(physiology)
- Male
- Metabolic Diseases
(blood, etiology)
- Middle Aged
- Obesity
(blood, complications)
- Overweight
(blood, complications)
- Renal Dialysis
(methods)
- Risk Factors
- Triglycerides
(blood)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|